Ibsa
1 products tracked · names used in filings: Ibsa
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 16 Dec 2025🇺🇸 FDA approval
FDA approves Vybrique (sildenafil citrate): new dosage form
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Vybrique sildenafil citrate | Approved | 2025-12-16 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.